Research progress of capecitabine combined chemotherapy with biweekly scheme / 基础医学与临床
Basic & Clinical Medicine
; (12): 884-888, 2017.
Article
de Zh
| WPRIM
| ID: wpr-612293
Bibliothèque responsable:
WPRO
ABSTRACT
As an oral chemotherapy drug, capecitabine is safe, effective and easy to use, has been widely used in the treatment of esophageal cancer, gastric cancer, colorectal cancer, breast cancer, ovarian cancer and other solid tumor.The chemotherapy scheme is mainly for 3 weeks, each cycle of capecitabine for 14 days, and 7 days off.As a modification to conventional chemotherapy, the biweekly scheme with capecitabine showed low toxicity and well tolerated by patients, short hospitalization time and other characteristics, it is worth of application in clinical.
Texte intégral:
1
Indice:
WPRIM
langue:
Zh
Texte intégral:
Basic & Clinical Medicine
Année:
2017
Type:
Article